{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T14:35:16Z","timestamp":1788014116467,"version":"build-2784847793"},"reference-count":116,"publisher":"MDPI AG","issue":"24","license":[{"start":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T00:00:00Z","timestamp":1638835200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003704","name":"Korea Research Institute of Chemical Technology","doi-asserted-by":"publisher","award":["SI-2132-20"],"award-info":[{"award-number":["SI-2132-20"]}],"id":[{"id":"10.13039\/501100003704","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003704","name":"Korea Research Institute of Chemical Technology","doi-asserted-by":"publisher","award":["KK2032-10"],"award-info":[{"award-number":["KK2032-10"]}],"id":[{"id":"10.13039\/501100003704","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Hepatitis B virus (HBV) is a major causative agent of human hepatitis. Its viral genome comprises partially double-stranded DNA, which is complexed with viral polymerase within an icosahedral capsid consisting of a dimeric core protein. Here, we describe the effects of capsid assembly modulators (CAMs) on the geometric or kinetic disruption of capsid construction and the virus life cycle. We highlight classical, early-generation CAMs such as heteroaryldihydropyrimidines, phenylpropenamides or sulfamoylbenzamides, and focus on the chemical structure and antiviral efficacy of recently identified non-classical CAMs, which consist of carboxamides, aryl ureas, bithiazoles, hydrazones, benzylpyridazinones, pyrimidines, quinolines, dyes, and antimicrobial compounds. We summarize the therapeutic efficacy of four representative classical compounds with data from clinical phase 1 studies in chronic HBV patients. Most of these compounds are in phase 2 trials, either as monotherapy or in combination with approved nucleos(t)ides drugs or other immunostimulatory molecules. As followers of the early CAMs, the therapeutic efficacy of several non-classical CAMs has been evaluated in humanized mouse models of HBV infection. It is expected that these next-generation HBV CAMs will be promising candidates for a series of extended human clinical trials.<\/jats:p>","DOI":"10.3390\/molecules26247420","type":"journal-article","created":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T11:00:23Z","timestamp":1638874823000},"page":"7420","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Current Progress in the Development of Hepatitis B Virus Capsid Assembly Modulators: Chemical Structure, Mode-of-Action and Efficacy"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6797-2360","authenticated-orcid":false,"given":"Hyejin","family":"Kim","sequence":"first","affiliation":[{"name":"Infectious Diseases Therapeutic Research Center, Korea Research Institute of Chemical Technology (KRICT), Daejeon 34114, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6512-1602","authenticated-orcid":false,"given":"Chunkyu","family":"Ko","sequence":"additional","affiliation":[{"name":"Infectious Diseases Therapeutic Research Center, Korea Research Institute of Chemical Technology (KRICT), Daejeon 34114, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5685-9875","authenticated-orcid":false,"given":"Joo-Youn","family":"Lee","sequence":"additional","affiliation":[{"name":"Infectious Diseases Therapeutic Research Center, Korea Research Institute of Chemical Technology (KRICT), Daejeon 34114, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2851-5298","authenticated-orcid":false,"given":"Meehyein","family":"Kim","sequence":"additional","affiliation":[{"name":"Infectious Diseases Therapeutic Research Center, Korea Research Institute of Chemical Technology (KRICT), Daejeon 34114, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,12,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Iannacone, M., and Guidotti, L.G. (2021). Immunobiology and pathogenesis of hepatitis B virus infection. Nat. Rev. Immunol.","DOI":"10.1038\/s41577-021-00549-4"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/j.vaccine.2011.12.116","article-title":"Global epidemiology of hepatitis B virus infection: New estimates of age-specific HBsAg seroprevalence and endemicity","volume":"30","author":"Ott","year":"2012","journal-title":"Vaccine"},{"key":"ref_3","unstructured":"(2021, November 23). Centers for Disease Control and Prevention, STI Treatment Guidelines, Available online: https:\/\/www.cdc.gov\/std\/treatment-guidelines\/hbv.htm."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1128\/CMR.00009-07","article-title":"Molecular testing in the diagnosis and management of chronic hepatitis B","volume":"20","author":"Valsamakis","year":"2007","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_5","unstructured":"World Health Organization (2021, October 05). Hepatitis B. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-b."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"10538","DOI":"10.1128\/JVI.00462-09","article-title":"A genetic variant of hepatitis B virus divergent from known human and ape genotypes isolated from a Japanese patient and provisionally assigned to new genotype J","volume":"83","author":"Tatematsu","year":"2009","journal-title":"J. Virol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Velkov, S., Ott, J.J., Protzer, U., and Michler, T. (2018). The Global Hepatitis B Virus Genotype Distribution Approximated from Available Genotyping Data. Genes, 9.","DOI":"10.3390\/genes9100495"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1159\/000080872","article-title":"Genetic diversity of hepatitis B virus strains derived worldwide: Genotypes, subgenotypes, and HBsAg subtypes","volume":"47","author":"Norder","year":"2004","journal-title":"Intervirology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1056\/NEJMcp041507","article-title":"Clinical practice: Prevention of hepatitis B with the hepatitis B vaccine","volume":"351","author":"Poland","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1002\/hep.20716","article-title":"Molecular analysis of HLA class II associations with hepatitis B virus clearance and vaccine nonresponsiveness","volume":"41","author":"Godkin","year":"2005","journal-title":"Hepatology"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1084\/jem.173.3.531","article-title":"The cellular basis for lack of antibody response to hepatitis B vaccine in humans","volume":"173","author":"Egea","year":"1991","journal-title":"J. Exp. Med."},{"key":"ref_12","first-page":"92","article-title":"Hepatitis B Virus Infection during Pregnancy: Transmission and Prevention","volume":"3","author":"Navabakhsh","year":"2011","journal-title":"Middle East J. Dig. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/hep.28156","article-title":"AASLD guidelines for treatment of chronic hepatitis B","volume":"63","author":"Terrault","year":"2016","journal-title":"Hepatology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"5390","DOI":"10.1038\/s41598-018-23525-w","article-title":"Direct antiviral properties of TLR ligands against HBV replication in immune-competent hepatocytes","volume":"8","author":"Lucifora","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Lam, A.M., Ren, S., Espiritu, C., Kelly, M., Lau, V., Zheng, L., Hartman, G.D., Flores, O.A., and Klumpp, K. (2017). Hepatitis B Virus Capsid Assembly Modulators, but Not Nucleoside Analogs, Inhibit the Production of Extracellular Pregenomic RNA and Spliced RNA Variants. Antimicrob. Agents Chemother., 61.","DOI":"10.1128\/AAC.00680-17"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/hep.1840380410","article-title":"Inhibition of HBV replication by siRNA in a stable HBV-producing cell line","volume":"38","author":"Konishi","year":"2003","journal-title":"Hepatology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jcmgh.2018.10.010","article-title":"Inhibition of HBV Transcription from cccDNA with Nitazoxanide by Targeting the HBx-DDB1 Interaction","volume":"7","author":"Sekiba","year":"2019","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"10833","DOI":"10.1038\/srep10833","article-title":"CRISPR\/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus","volume":"5","author":"Ramanan","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.jhep.2016.11.009","article-title":"Cyclosporin derivatives inhibit hepatitis B virus entry without interfering with NTCP transporter activity","volume":"66","author":"Shimura","year":"2017","journal-title":"J. Hepatol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/hep.28013","article-title":"A targeted functional RNA interference screen uncovers glypican 5 as an entry factor for hepatitis B and D viruses","volume":"63","author":"Verrier","year":"2016","journal-title":"Hepatology"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1053\/j.gastro.2013.12.024","article-title":"Hepatitis B and D Viruses Exploit Sodium Taurocholate Co-transporting Polypeptide for Species-Specific Entry into Hepatocytes","volume":"146","author":"Ni","year":"2014","journal-title":"Gastroenterology"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e00049","DOI":"10.7554\/eLife.00049","article-title":"Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus","volume":"1","author":"Yan","year":"2012","journal-title":"eLife"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e13250","DOI":"10.1111\/cmi.13250","article-title":"Synchronised infection identifies early rate-limiting steps in the hepatitis B virus life cycle","volume":"22","author":"Chakraborty","year":"2020","journal-title":"Cell. Microbiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"8487","DOI":"10.1073\/pnas.1811064116","article-title":"Epidermal growth factor receptor is a host-entry cofactor triggering hepatitis B virus internalization","volume":"116","author":"Iwamoto","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1038\/s41467-021-21850-9","article-title":"Hepatitis B virus cccDNA is formed through distinct repair processes of each strand","volume":"12","author":"Wei","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/s41564-020-0678-0","article-title":"Core components of DNA lagging strand synthesis machinery are essential for hepatitis B virus cccDNA formation","volume":"5","author":"Wei","year":"2020","journal-title":"Nat. Microbiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e02230-18","DOI":"10.1128\/JVI.02230-18","article-title":"Cellular DNA Topoisomerases Are Required for the Synthesis of Hepatitis B Virus Covalently Closed Circular DNA","volume":"93","author":"Sheraz","year":"2019","journal-title":"J. Virol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Kitamura, K., Que, L., Shimadu, M., Koura, M., Ishihara, Y., Wakae, K., Nakamura, T., Watashi, K., Wakita, T., and Muramatsu, M. (2018). Flap endonuclease 1 is involved in cccDNA formation in the hepatitis B virus. PLoS Pathog., 14.","DOI":"10.1371\/journal.ppat.1007124"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Long, Q., Yan, R., Hu, J., Cai, D., Mitra, B., Kim, E.S., Marchetti, A., Zhang, H., Wang, S., and Liu, Y. (2017). The role of host DNA ligases in hepadnavirus covalently closed circular DNA formation. PLoS Pathog., 13.","DOI":"10.1371\/journal.ppat.1006784"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"E4244","DOI":"10.1073\/pnas.1409986111","article-title":"Involvement of the host DNA-repair enzyme TDP2 in formation of the covalently closed circular DNA persistence reservoir of hepatitis B viruses","volume":"111","author":"Koniger","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1136\/gutjnl-2015-309809","article-title":"HBV cccDNA: Viral persistence reservoir and key obstacle for a cure of chronic hepatitis B","volume":"64","author":"Nassal","year":"2015","journal-title":"Gut"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1002\/hep.29479","article-title":"Epigenetic regulation of hepatitis B virus covalently closed circular DNA: Implications for epigenetic therapy against chronic hepatitis B","volume":"66","author":"Hong","year":"2017","journal-title":"Hepatology"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"100330","DOI":"10.1016\/j.jhepr.2021.100330","article-title":"Evidence for long-term association of virion-delivered HBV core protein with cccDNA independently of viral protein production","volume":"3","author":"Lucifora","year":"2021","journal-title":"JHEP Rep."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1006\/jmbi.2000.4481","article-title":"Structural organization of the hepatitis B virus minichromosome","volume":"307","author":"Bock","year":"2001","journal-title":"J. Mol. Biol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"19975","DOI":"10.1073\/pnas.0908365106","article-title":"Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function","volume":"106","author":"Belloni","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1016\/j.celrep.2016.08.026","article-title":"Hepatitis B Virus X Protein Promotes Degradation of SMC5\/6 to Enhance HBV Replication","volume":"16","author":"Murphy","year":"2016","journal-title":"Cell Rep."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/nature17170","article-title":"Hepatitis B virus X protein identifies the Smc5\/6 complex as a host restriction factor","volume":"531","author":"Decorsiere","year":"2016","journal-title":"Nature"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.jhep.2015.06.023","article-title":"HBx relieves chromatin-mediated transcriptional repression of hepatitis B viral cccDNA involving SETDB1 histone methyltransferase","volume":"63","author":"Riviere","year":"2015","journal-title":"J. Hepatol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.jhep.2011.02.015","article-title":"Hepatitis B virus X protein is essential to initiate and maintain virus replication after infection","volume":"55","author":"Lucifora","year":"2011","journal-title":"J. Hepatol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"720","DOI":"10.4161\/epi.6.6.15815","article-title":"HBc binds to the CpG islands of HBV cccDNA and promotes an epigenetic permissive state","volume":"6","author":"Guo","year":"2011","journal-title":"Epigenetics"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2017.05.003","article-title":"Role of hepatitis B core protein in HBV transcription and recruitment of histone acetyltransferases to cccDNA minichromosome","volume":"144","author":"Chong","year":"2017","journal-title":"Antiviral Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"100195","DOI":"10.1016\/j.jhepr.2020.100195","article-title":"De novo synthesis of hepatitis B virus nucleocapsids is dispensable for the maintenance and transcriptional regulation of cccDNA","volume":"3","author":"Tu","year":"2021","journal-title":"JHEP Rep."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/0092-8674(82)90157-X","article-title":"Replication of the genome of a hepatitis B\u2014Like virus by reverse transcription of an RNA intermediate","volume":"29","author":"Summers","year":"1982","journal-title":"Cell"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"5324","DOI":"10.1128\/jvi.64.11.5324-5332.1990","article-title":"The P gene product of hepatitis B virus is required as a structural component for genomic RNA encapsidation","volume":"64","author":"Bartenschlager","year":"1990","journal-title":"J. Virol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1002\/j.1460-2075.1990.tb07540.x","article-title":"A short cis-acting sequence is required for hepatitis B virus pregenome encapsidation and sufficient for packaging of foreign RNA","volume":"9","author":"Bartenschlager","year":"1990","journal-title":"EMBO J."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1128\/JVI.01957-10","article-title":"The arginine clusters of the carboxy-terminal domain of the core protein of hepatitis B virus make pleiotropic contributions to genome replication","volume":"85","author":"Lewellyn","year":"2011","journal-title":"J. Virol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"4107","DOI":"10.1128\/jvi.66.7.4107-4116.1992","article-title":"The arginine-rich domain of the hepatitis B virus core protein is required for pregenome encapsidation and productive viral positive-strand DNA synthesis but not for virus assembly","volume":"66","author":"Nassal","year":"1992","journal-title":"J. Virol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1128\/JVI.03235-13","article-title":"Nucleic acid chaperone activity associated with the arginine-rich domain of human hepatitis B virus core protein","volume":"88","author":"Chu","year":"2014","journal-title":"J. Virol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"10205","DOI":"10.1073\/pnas.0704000104","article-title":"Involvement of host cellular multivesicular body functions in hepatitis B virus budding","volume":"104","author":"Watanabe","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.jhep.2018.08.012","article-title":"Hepatitis B virus genome recycling and de novo secondary infection events maintain stable cccDNA levels","volume":"69","author":"Ko","year":"2018","journal-title":"J. Hepatol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.antiviral.2015.06.020","article-title":"Core protein: A pleiotropic keystone in the HBV lifecycle","volume":"121","author":"Zlotnick","year":"2015","journal-title":"Antiviral Res."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"de Rocquigny, H., Rat, V., Pastor, F., Darlix, J.L., Hourioux, C., and Roingeard, P. (2020). Phosphorylation of the Arginine-Rich C-Terminal Domains of the Hepatitis B Virus (HBV) Core Protein as a Fine Regulator of the Interaction between HBc and Nucleic Acid. Viruses, 12.","DOI":"10.3390\/v12070738"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Li, H.C., Huang, E.Y., Su, P.Y., Wu, S.Y., Yang, C.C., Lin, Y.S., Chang, W.C., and Shih, C. (2010). Nuclear export and import of human hepatitis B virus capsid protein and particles. PLoS Pathog., 6.","DOI":"10.1371\/journal.ppat.1001162"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"3802","DOI":"10.1016\/j.jmb.2020.04.026","article-title":"Hepatitis B Virus Core Protein Domains Essential for Viral Capsid Assembly in a Cellular Context","volume":"432","author":"Rat","year":"2020","journal-title":"J. Mol. Biol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"5830","DOI":"10.1128\/JVI.00394-16","article-title":"Cell-Free Hepatitis B Virus Capsid Assembly Dependent on the Core Protein C-Terminal Domain and Regulated by Phosphorylation","volume":"90","author":"Ludgate","year":"2016","journal-title":"J. Virol."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Liu, K., Luckenbaugh, L., Ning, X., Xi, J., and Hu, J. (2018). Multiple roles of core protein linker in hepatitis B virus replication. PLoS Pathog., 14.","DOI":"10.1371\/journal.ppat.1007085"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S1097-2765(01)80009-5","article-title":"The crystal structure of the human hepatitis B virus capsid","volume":"3","author":"Wynne","year":"1999","journal-title":"Mol. Cell"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/jmr.801","article-title":"BAY 41-4109 has multiple effects on Hepatitis B virus capsid assembly","volume":"19","author":"Stray","year":"2006","journal-title":"J. Mol. Recognit."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"5344","DOI":"10.1128\/AAC.01091-13","article-title":"Preclinical characterization of GLS4, an inhibitor of hepatitis B virus core particle assembly","volume":"57","author":"Wu","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Mani, N., Cole, A.G., Phelps, J.R., Ardzinski, A., Cobarrubias, K.D., Cuconati, A., Dorsey, B.D., Evangelista, E., Fan, K., and Guo, F. (2018). Preclinical Profile of AB-423, an Inhibitor of Hepatitis B Virus Pregenomic RNA Encapsidation. Antimicrob. Agents Chemother., 62.","DOI":"10.1128\/AAC.00082-18"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.antiviral.2007.06.014","article-title":"The phenylpropenamide derivative AT-130 blocks HBV replication at the level of viral RNA packaging","volume":"76","author":"Feld","year":"2007","journal-title":"Antiviral Res."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"6931","DOI":"10.1128\/JVI.00582-13","article-title":"Sulfamoylbenzamide derivatives inhibit the assembly of hepatitis B virus nucleocapsids","volume":"87","author":"Campagna","year":"2013","journal-title":"J. Virol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"e01701-19","DOI":"10.1128\/AAC.01701-19","article-title":"Novel Hepatitis B Virus Capsid Assembly Modulator Induces Potent Antiviral Responses In Vitro and in Humanized Mice","volume":"64","author":"Amblard","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.str.2013.06.013","article-title":"Assembly-directed antivirals differentially bind quasiequivalent pockets to modify hepatitis B virus capsid tertiary and quaternary structure","volume":"21","author":"Katen","year":"2013","journal-title":"Structure"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"11055","DOI":"10.1128\/JVI.00933-06","article-title":"Global structural changes in hepatitis B virus capsids induced by the assembly effector HAP1","volume":"80","author":"Bourne","year":"2006","journal-title":"J. Virol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"42374","DOI":"10.1038\/srep42374","article-title":"Heteroaryldihydropyrimidine (HAP) and Sulfamoylbenzamide (SBA) Inhibit Hepatitis B Virus Replication by Different Molecular Mechanisms","volume":"7","author":"Zhou","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"15196","DOI":"10.1073\/pnas.1513803112","article-title":"High-resolution crystal structure of a hepatitis B virus replication inhibitor bound to the viral core protein","volume":"112","author":"Klumpp","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1126\/science.1077215","article-title":"Inhibition of hepatitis B virus replication by drug-induced depletion of nucleocapsids","volume":"299","author":"Deres","year":"2003","journal-title":"Science"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0166-3542(01)00216-9","article-title":"Inhibition of human hepatitis B virus (HBV) by a novel non-nucleosidic compound in a transgenic mouse model","volume":"54","author":"Weber","year":"2002","journal-title":"Antiviral Res."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"e00131-18","DOI":"10.1128\/mSphereDirect.00131-18","article-title":"The Heteroaryldihydropyrimidine Bay 38-7690 Induces Hepatitis B Virus Core Protein Aggregates Associated with Promyelocytic Leukemia Nuclear Bodies in Infected Cells","volume":"3","author":"Huber","year":"2018","journal-title":"mSphere"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.antiviral.2018.07.011","article-title":"Novel non-heteroarylpyrimidine (HAP) capsid assembly modifiers have a different mode of action from HAPs in vitro","volume":"158","author":"Corcuera","year":"2018","journal-title":"Antiviral Res."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"104557","DOI":"10.1016\/j.antiviral.2019.104557","article-title":"BAY 41-4109-mediated aggregation of assembled and misassembled HBV capsids in cells revealed by electron microscopy","volume":"169","author":"Rat","year":"2019","journal-title":"Antiviral Res."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"e02139-17","DOI":"10.1128\/JVI.02139-17","article-title":"Hepatitis B Virus Core Protein Dephosphorylation Occurs during Pregenomic RNA Encapsidation","volume":"92","author":"Zhao","year":"2018","journal-title":"J. Virol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"e01440-19","DOI":"10.1128\/AAC.01440-19","article-title":"A New Role for Capsid Assembly Modulators to Target Mature Hepatitis B Virus Capsids and Prevent Virus Infection","volume":"64","author":"Ko","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"e00835-18","DOI":"10.1128\/AAC.00835-18","article-title":"Novel Potent Capsid Assembly Modulators Regulate Multiple Steps of the Hepatitis B Virus Life Cycle","volume":"62","author":"Lahlali","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Guo, F., Zhao, Q., Sheraz, M., Cheng, J., Qi, Y., Su, Q., Cuconati, A., Wei, L., Du, Y., and Li, W. (2017). HBV core protein allosteric modulators differentially alter cccDNA biosynthesis from de novo infection and intracellular amplification pathways. PLoS Pathog., 13.","DOI":"10.1371\/journal.ppat.1006658"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"e00560-17","DOI":"10.1128\/AAC.00560-17","article-title":"Capsid Assembly Modulators Have a Dual Mechanism of Action in Primary Human Hepatocytes Infected with Hepatitis B Virus","volume":"61","author":"Berke","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"e01463-20","DOI":"10.1128\/AAC.01463-20","article-title":"Preclinical Profile and Characterization of the Hepatitis B Virus Core Protein Inhibitor ABI-H0731","volume":"64","author":"Huang","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"e32478","DOI":"10.7554\/eLife.32478","article-title":"All-atom molecular dynamics of the HBV capsid reveals insights into biological function and cryo-EM resolution limits","volume":"7","author":"Hadden","year":"2018","journal-title":"eLife"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"e31473","DOI":"10.7554\/eLife.31473","article-title":"Hepatitis B virus core protein allosteric modulators can distort and disrupt intact capsids","volume":"7","author":"Schlicksup","year":"2018","journal-title":"eLife"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1126\/science.1243462","article-title":"Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA","volume":"343","author":"Lucifora","year":"2014","journal-title":"Science"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1021\/acsinfecdis.7b00144","article-title":"Discovery of Small Molecule Therapeutics for Treatment of Chronic HBV Infection","volume":"4","author":"Feng","year":"2018","journal-title":"ACS Infect. Dis."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.cbpa.2019.02.009","article-title":"Recent advances in the development of HBV capsid assembly modulators","volume":"50","author":"Nijampatnam","year":"2019","journal-title":"Curr. Opin. Chem. Biol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1021\/acsinfecdis.8b00337","article-title":"Treatment of Chronic Hepatitis B Virus Infection Using Small Molecule Modulators of Nucleocapsid Assembly: Recent Advances and Perspectives","volume":"5","author":"Yang","year":"2019","journal-title":"ACS Infect. Dis."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"104917","DOI":"10.1016\/j.antiviral.2020.104917","article-title":"Targeting the multifunctional HBV core protein as a potential cure for chronic hepatitis B","volume":"182","author":"Viswanathan","year":"2020","journal-title":"Antiviral Res."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"710","DOI":"10.2174\/157340641108151029111243","article-title":"Review of Small Synthetic Molecules Targeting HBV Capsid Assembly","volume":"11","author":"Liu","year":"2015","journal-title":"Med. Chem."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"e00519-17","DOI":"10.1128\/JVI.00519-17","article-title":"Discovery and Mechanistic Study of Benzamide Derivatives That Modulate Hepatitis B Virus Capsid Assembly","volume":"91","author":"Wu","year":"2017","journal-title":"J. Virol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1021\/acsinfecdis.8b00269","article-title":"Discovery of novel hepatitis B virus nucleocapsid assembly inhibitors","volume":"5","author":"Zhang","year":"2019","journal-title":"ACS Infect. Dis."},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Xiao, Y., Liu, C., Tang, W., Zhang, H., and Chen, X. (2019). Evans Blue Inhibits HBV Replication Through a Dual Antiviral Mechanism by Targeting Virus Binding and Capsid Assembly. Front. Microbiol., 10.","DOI":"10.3389\/fmicb.2019.02638"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ejmech.2018.12.047","article-title":"5-Aminothiophene-2,4-dicarboxamide analogues as hepatitis B virus capsid assembly effectors","volume":"164","author":"Tang","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1021\/acsinfecdis.8b00235","article-title":"Novel Hepatitis B Virus Capsid-Targeting Antiviral That Aggregates Core Particles and Inhibits Nuclear Entry of Viral Cores","volume":"5","author":"Huber","year":"2019","journal-title":"ACS Infect. Dis."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Senaweera, S., Du, H., Zhang, H., Kirby, K.A., Tedbury, P.R., Xie, J., Sarafianos, S.G., and Wang, Z. (2021). Discovery of New Small Molecule Hits as Hepatitis B Virus Capsid Assembly Modulators: Structure and Pharmacophore-Based Approaches. Viruses, 13.","DOI":"10.3390\/v13050770"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1021\/acsinfecdis.9b00030","article-title":"Discovery of New Hepatitis B Virus Capsid Assembly Modulators by an Optimal High-Throughput Cell-Based Assay","volume":"5","author":"Pei","year":"2019","journal-title":"ACS Infect. Dis."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00044-020-02677-3","article-title":"Synthesis of 4-oxotetrahydropyrimidine-1(2H)-carboxamides derivatives as capsid assembly modulators of hepatitis B virus","volume":"30","author":"Hwang","year":"2021","journal-title":"Med. Chem. Res."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"127848","DOI":"10.1016\/j.bmcl.2021.127848","article-title":"Identification of a new class of HBV capsid assembly modulator","volume":"39","author":"Kuduk","year":"2021","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_96","unstructured":"Hu, T., Han, X., Kou, B., Shen, H., Yan, S., and Zhang, Z. (2018). Pyrazine Compounds for the Treatment of Infectious Diseases. (9,890,167), U.S. Patent."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/aps.2013.175","article-title":"Isothiafludine, a novel non-nucleoside compound, inhibits hepatitis B virus replication through blocking pregenomic RNA encapsidation","volume":"35","author":"Yang","year":"2014","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.antiviral.2015.11.004","article-title":"Effect of a hepatitis B virus inhibitor, NZ-4, on capsid formation","volume":"125","author":"Yang","year":"2016","journal-title":"Antiviral Res."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"112495","DOI":"10.1016\/j.ejmech.2020.112495","article-title":"Design, diversity-oriented synthesis and biological evaluation of novel heterocycle derivatives as non-nucleoside HBV capsid protein inhibitors","volume":"202","author":"Jia","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Yamasaki, M., Matsuda, N., Matoba, K., Kondo, S., Kanegae, Y., Saito, I., and Nomoto, A. (2021). Acetophenone 4-nitrophenylhydrazone inhibits Hepatitis B virus replication by modulating capsid assembly. Virus Res., 198565.","DOI":"10.1016\/j.virusres.2021.198565"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"7061","DOI":"10.1128\/AAC.01558-15","article-title":"A novel pyridazinone derivative inhibits hepatitis B virus replication by inducing genome-free capsid formation","volume":"59","author":"Wang","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"8134","DOI":"10.1021\/acs.jmedchem.0c00346","article-title":"Discovery of Phthalazinone Derivatives as Novel Hepatitis B Virus Capsid Inhibitors","volume":"63","author":"Chen","year":"2020","journal-title":"J. Med. Chem."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"197677","DOI":"10.1016\/j.virusres.2019.197677","article-title":"Pyrimidotriazine derivatives as selective inhibitors of HBV capsid assembly","volume":"271","author":"Toyama","year":"2019","journal-title":"Virus Res."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"5500","DOI":"10.1021\/acs.jmedchem.0c01938","article-title":"Discovery of Novel Pyrimidine-Based Capsid Assembly Modulators as Potent Anti-HBV Agents","volume":"64","author":"Kim","year":"2021","journal-title":"J. Med. Chem."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"116096","DOI":"10.1016\/j.bmc.2021.116096","article-title":"Discovery of novel HBV capsid assembly modulators by structure-based virtual screening and bioassays","volume":"36","author":"Wang","year":"2021","journal-title":"Biorg. Med. Chem."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"4848","DOI":"10.1128\/JVI.76.10.4848-4854.2002","article-title":"A small molecule inhibits and misdirects assembly of hepatitis B virus capsids","volume":"76","author":"Zlotnick","year":"2002","journal-title":"J. Virol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.virusres.2019.01.004","article-title":"Cetylpyridinium chloride interaction with the hepatitis B virus core protein inhibits capsid assembly","volume":"263","author":"Seo","year":"2019","journal-title":"Virus Res."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1038\/s41467-019-10200-5","article-title":"Ciclopirox inhibits Hepatitis B Virus secretion by blocking capsid assembly","volume":"10","author":"Kang","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S2468-1253(19)30346-2","article-title":"Safety, pharmacokinetics, and antiviral effects of ABI-H0731, a hepatitis B virus core inhibitor: A randomised, placebo-controlled phase 1 trial","volume":"5","author":"Yuen","year":"2020","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.bmc.2016.12.017","article-title":"Discovery of hepatitis B virus capsid assembly inhibitors leading to a heteroaryldihydropyrimidine based clinical candidate (GLS4)","volume":"25","author":"Ren","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/cid\/ciaa961","article-title":"Antiviral Activity and Pharmacokinetics of the Hepatitis B Virus (HBV) Capsid Assembly Modulator GLS4 in Patients with Chronic HBV Infection","volume":"73","author":"Zhang","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Zhao, N., Jia, B., Zhao, H., Xu, J., Sheng, X., Luo, L., Huang, Z., Wang, X., Ren, Q., and Zhang, Y. (2019). A First-in-Human Trial of GLS4, a Novel Inhibitor of Hepatitis B Virus Capsid Assembly, following Single- and Multiple-Ascending-Oral-Dose Studies with or without Ritonavir in Healthy Adult Volunteers. Antimicrob. Agents Chemother., 64.","DOI":"10.1128\/AAC.01686-19"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1053\/j.gastro.2020.04.036","article-title":"JNJ-56136379, an HBV Capsid Assembly Modulator, Is Well-Tolerated and Has Antiviral Activity in a Phase 1 Study of Patients with Chronic Infection","volume":"159","author":"Zoulim","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"S129","DOI":"10.1016\/S0168-8278(20)30773-X","article-title":"Efficacy and Safety Results of the Phase 2 JNJ-56136379 JADE Study in Patients with Chronic Hepatitis B: Interim Week 24 Data","volume":"73","author":"Janssen","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"S770","DOI":"10.1016\/S0168-8278(18)31805-1","article-title":"In vitro and in vivo antiviral characterization of RO7049389, a novel small molecule capsid assembly modulator for the treatment of chronic hepatitis B","volume":"68","author":"Zhou","year":"2018","journal-title":"J. Hepatol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S2468-1253(21)00176-X","article-title":"Safety, pharmacokinetics, and antiviral activity of RO7049389, a core protein allosteric modulator, in patients with chronic hepatitis B virus infection: A multicentre, randomised, placebo-controlled, phase 1 trial","volume":"6","author":"Yuen","year":"2021","journal-title":"Lancet Gastroenterol. Hepatol."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/26\/24\/7420\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:42:34Z","timestamp":1760168554000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/26\/24\/7420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,7]]},"references-count":116,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["molecules26247420"],"URL":"https:\/\/doi.org\/10.3390\/molecules26247420","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,7]]}}}